Community Questions & Discussions

Discussing the DS-7011a Study in Lupus Patients: What to Consider?

I recently came across a study on DS-7011a in patients with lupus and I'm curious to hear your thoughts on it. The main goal of the study is to evaluate the safety, tolerability, and efficacy of DS-7011a in patients with active lupus nephritis. What are your thoughts on the goals and potential outco...

  • By Admin

Thoughts on the Long-Term Voclosporin Treatment Study for Lupus Nephritis in Teens?

I'm curious to hear your thoughts on the recent study titled 'Long-Term Voclosporin Treatment in Adolescent Subjects With Lupus Nephritis'. This phase II trial aimed to evaluate the safety and efficacy of voclosporin in adolescents with active lupus nephritis. What do you think about the goals and o...

  • By Admin

Thoughts on the Recent ESK-001 Clinical Trial for Lupus?

I came across a recent phase 2 clinical trial for lupus, and I'm curious to hear your thoughts. The study, 'Phase 2 Placebo-Controlled Study to Assess the Safety and Effectiveness of ESK-001 in Active Lupus,' evaluates a new treatment approach for addressing lupus challenges. What are your thoughts ...

  • By Admin

Thoughts on the 'Effectiveness And Safety Of MK-6194 In Adult Patients With Lupus' clinical trial

I recently came across the 'Effectiveness And Safety Of MK-6194 In Adult Patients With Lupus' study and I'm curious to hear your thoughts. The trial aims to address lupus challenges by evaluating a new investigational drug called MK-6194. What are your opinions on this approach? Do you think it coul...

  • By Admin

Thoughts on a New Study About Hydroxychloroquine and Lupus

I recently came across a study titled 'Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With Lupus' and it got me thinking about what we all think about the goals and outcomes of this research. As many of us know, hydroxychloroquine is a common treatment for lup...

  • By Admin

Thoughts on the 'Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity' study for autoimmune diseases

I recently came across a study titled 'Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity' that aims to address health disparities in rheumatology care for autoimmune diseases like lupus. The study focuses on identifying and addressing social determinants of health to...

  • By Admin

Thoughts on the 'Study on IMPT-514 in Active Refractory Lupus (SLE)' Clinical Trial?

Hey everyone, I recently came across a clinical trial for lupus that I wanted to get your thoughts on. The study is titled 'Study on IMPT-514 in Active Refractory Lupus (SLE)'. The main goal of this trial is to evaluate the safety and efficacy of IMPT-514 in treating active refractory lupus, which a...

  • By Admin

Thoughts on the GLEAM Study Addressing Lupus Challenges

Have any of you heard about the 'Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)' study? This phase 2 trial is investigating a new treatment approach for patients with severe and refractory autoimmune diseases, including lupus. The drug being tested, SC...

  • By Admin

Thoughts on the Anifrolumab Study for Lupus: A Step in the Right Direction?

I recently came across the 'The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Lupus (SLE) - IFN-CVD' study, which explores a potential new treatment for lupus. The approach focuses on addressing vascular risk markers, which is an interesting angle. What are your thoughts...

  • By Admin

Thoughts on the Long-term Safety Study of Ianalumab in Lupus Patients?

I came across the 'Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Patients With Lupus (SIRIUS-SLE Extension)' and I'm curious to hear your thoughts. This study focuses on the safety of Ianalumab in lupus patients over an extended period. While it's important to assess the safet...

  • By Admin

Thoughts on the Goals and Outcomes of a Lupus Cutaneous Clinical Trial

I'm curious to hear your thoughts on the study titled 'A Study to Assess the Effectiveness and Safety of BIIB059 (Litifilimab) in Patients With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations and Refract...

  • By Admin

Thoughts on the Willow LTE Study with M5049 for SCLE, DLE and/or SLE

I came across the Willow LTE Study with M5049 in patients with Subacute Cutaneous Lupus Erythematosus (SCLE), Discoid Lupus Erythematosus (DLE) and/or Systemic Lupus Erythematosus (SLE). What are your thoughts on the goals and outcomes of this study?...

  • By Admin

Discussing the Impact of Anifrolumab on Vaccine-Emergent Immunity in Lupus Clinical Trial

I recently came across a clinical trial study titled 'Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE' and it got me thinking - what are your thoughts on the goals and outcomes of this study? The trial aims to evaluate the effect of Anifrolumab on the immune response to vaccines in ...

  • By Admin

Discussing the 'Centrally Acting ACE Inhibition in SLE' Clinical Trial: What's Your Take?

I recently came across the study titled 'Centrally Acting ACE Inhibition in SLE' and I'm interested in hearing your thoughts on its goals and outcomes. This trial focuses on using centrally acting ACE inhibitors to manage lupus nephritis, a common and severe complication of systemic lupus erythemato...

  • By Admin

FT819 in Moderate to Severe Active Lupus: What Do You Think?

I recently came across a study titled 'FT819 in Moderate to Severe Active Lupus' and I'm curious to hear your thoughts on the goals and potential outcomes of this trial. For those not familiar, FT819 is an investigational medicine being studied in a Phase 2 clinical trial for the treatment of lupus....

  • By Admin

Total Threads: 15 - 182